Zobrazeno 1 - 10
of 119
pro vyhledávání: '"Fabienne, Escande"'
Autor:
Laetitia Lebrun, Sacha Allard-Demoustiez, Nathalie Gilis, Claude Van Campenhout, Marine Rodesch, Celine Roman, Pierluigi Calò, Valentina Lolli, Philippe David, Christophe Fricx, Olivier De Witte, Fabienne Escande, Claude-Alain Maurage, Isabelle Salmon
Publikováno v:
Acta Neuropathologica Communications, Vol 11, Iss 1, Pp 1-7 (2023)
Abstract Central Nervous System (CNS) embryonal tumors represent a heterogeneous group of highly aggressive tumors occurring preferentially in children but also described in adolescents and adults. In 2021, the CNS World Health Organization (WHO) cla
Externí odkaz:
https://doaj.org/article/a7e8b77961374116afca9f04379b01e9
Autor:
Camille Ardin, Sarah Humez, Vincent Leroy, Alexandre Ampere, Soraya Bordier, Fabienne Escande, Amélie Turlotte, Luc Stoven, David Nunes, Alexis Cortot, Clément Gauvain
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Background: The optimal duration of immune checkpoint inhibitor (ICI) treatment for patients with advanced non-small cell lung cancer (NSCLC) remains to be determined. Treatment durations in cornerstone phase 3 clinical trials vary between a fixed 2-
Externí odkaz:
https://doaj.org/article/eb9dd7e9b3524025b2ea8b7fb0b18c7d
Autor:
Marie Duhamel, Lauranne Drelich, Maxence Wisztorski, Soulaimane Aboulouard, Jean-Pascal Gimeno, Nina Ogrinc, Patrick Devos, Tristan Cardon, Michael Weller, Fabienne Escande, Fahed Zairi, Claude-Alain Maurage, Émilie Le Rhun, Isabelle Fournier, Michel Salzet
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-16 (2022)
Characterisation of molecular heterogeneity in glioblastoma would improve patient stratification. Here, the authors integrate spatial proteomics and clinical data from glioblastoma patients and identify 3 molecular groups and a 5-protein signature th
Externí odkaz:
https://doaj.org/article/a3c577b117894ed0860c09c147501935
Autor:
Endika Haro, Florence Petit, Charmaine U. Pira, Conor D. Spady, Sara Lucas-Toca, Lauren I. Yorozuya, Austin L. Gray, Fabienne Escande, Anne-Sophie Jourdain, Andy Nguyen, Florence Fellmann, Jean-Marc Good, Christine Francannet, Sylvie Manouvrier-Hanu, Marian A. Ros, Kerby C. Oberg
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-11 (2021)
Nail-patella syndrome (NPS) is characterized by nail dysplasia, absent/hypoplastic patellae, chronic kidney disease, and glaucoma and can be caused by haploinsufficiency of LMX1B; however, not all patients harbor pathogenic LMX1B mutations. Here the
Externí odkaz:
https://doaj.org/article/c839defb640841778feac8543d2361dc
Autor:
Chamara Sampath Paththinige, Nirmala Dushyanthi Sirisena, Fabienne Escande, Sylvie Manouvrier, Florence Petit, Vajira Harshadeva Weerabaddana Dissanayake
Publikováno v:
BMC Medical Genetics, Vol 20, Iss 1, Pp 1-7 (2019)
Abstract Background Split hand/foot malformation (SHFM) is a group of congenital skeletal disorders which may occur either as an isolated abnormality or in syndromic forms with extra-limb manifestations. Chromosomal micro-duplication or micro-triplic
Externí odkaz:
https://doaj.org/article/60b743b3c30a4c4ab374106343dc21ce
Autor:
Anne-Marie Ruppert, MD, PhD, Michèle Beau-Faller, MD, PhD, Didier Debieuvre, MD, L’Houcine Ouafik, MD, PhD, Virginie Westeel, MD PhD, Isabelle Rouquette, MD, Julien Mazières, MD, PhD, Pierre-Paul Bringuier, MD, Isabelle Monnet, MD, Fabienne Escande, MD, Charles Ricordel, MD, Jean-Philippe Merlio, MD, PDh, Henri Janicot, MD, Antoinette Lemoine, MD, PhD, Pascal Foucher, MD, Michel Poudenx, MD, Franck Morin, MSc, Alexandra Langlais, MSc, Pierre-Jean Souquet, MD, PhD, Fabrice Barlesi, MD, PhD, Marie Wislez, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 1, Iss 3, Pp 100052- (2020)
Introduction: KRAS mutations are detected in 20% to 30% of NSCLC. However, KRAS mutation subtypes may differently influence the outcome of patients with advanced NSCLC. Methods: In the Biomarkers France study, 4894 KRAS mutations (26.2%) were detecte
Externí odkaz:
https://doaj.org/article/0738da11c0534bb49bbf4eba273784d4
Autor:
Claude-Alain Maurage, Rabih Aboukais, Antoine Devalckeneer, Maxime Faisant, Fabienne Escande, Vannod-Michel Quentin, Philippe Bourgeois, Jean-Paul Lejeune
Publikováno v:
Neurosurgical Review. 45:1691-1699
WHO grade II progestin-related meningiomas have been reported in recent series but we found no previous study describing their long-term outcome. Our study aimed to evaluate patients operated on for high-grade intracranial meningioma and who underwen
Autor:
Andy Nguyen, Endika Haro, Florence Petit, Lauren I. Yorozuya, Kerby C. Oberg, Anne-Sophie Jourdain, Florence Fellmann, Conor D. Spady, Marian A. Ros, Sylvie Manouvrier-Hanu, Charmaine U. Pira, Christine Francannet, Jean-Marc Good, Sara Lucas-Toca, Fabienne Escande, Austin L. Gray
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-11 (2021)
Nature communications, vol. 12, no. 1, pp. 5533
Digital.CSIC. Repositorio Institucional del CSIC
instname
Nature Communications
Nature communications, vol. 12, no. 1, pp. 5533
Digital.CSIC. Repositorio Institucional del CSIC
instname
Nature Communications
© The Author(s) 2021.
LMX1B haploinsufficiency causes Nail-patella syndrome (NPS; MIM 161200), characterized by nail dysplasia, absent/hypoplastic patellae, chronic kidney disease, and glaucoma. Accordingly in mice, Lmx1b has been shown to play
LMX1B haploinsufficiency causes Nail-patella syndrome (NPS; MIM 161200), characterized by nail dysplasia, absent/hypoplastic patellae, chronic kidney disease, and glaucoma. Accordingly in mice, Lmx1b has been shown to play
Autor:
Solène-Florence, Kammerer-Jacquet, Camille, Gandon, Frederic, Dugay, Brigitte, Laguerre, Benoit, Peyronnet, Romain, Mathieu, Grégory, Verhoest, Karim, Bensalah, Xavier, Leroy, Sebastien, Aubert, Catherine, Vermaut, Fabienne, Escande, Virginie, Verkarre, Eva, Compérat, Damien, Ambrosetti, Florence, Pedeutour, Marc-Antoine, Belaud-Rotureau, Nathalie, Rioux-Leclercq
Publikováno v:
Histopathology
Histopathology, 2022, 81 (2), pp.228-238. ⟨10.1111/his.14683⟩
Histopathology, 2022, 81 (2), pp.228-238. ⟨10.1111/his.14683⟩
International audience; Aims First described in 2014, renal cell carcinoma (RCC) with TFEB amplification (6p21) is a rare molecular subgroup whose diagnosis is challenging. The prognosis and therapeutic implications remain unclear. Methods We report
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::dfb419aebb7aa3286b4ab6ee72ae3e5f
https://hal.science/hal-03711065
https://hal.science/hal-03711065
Autor:
Nicolas Jacquin, Maud Kamal, Ivan Bieche, Célia Dupain, Isabelle Guillou, Linda Larbi-Chérif, Etienne Rouleau, Julien Masliah Planchon, Isabelle Soubeyran, Christelle de la Fouchardière, Camille Tlemsani, Hélène Blons, Fabienne Escande, Michel Vidaud, Jennifer Wong, Pierre Saintigny, Sandrine Boyault, Adrien Buisson, Yves Allory, Anne Vincent-Salomon, Vincent Cockenpot, Janick Selves, Christophe Le Tourneau, Sarah Watson
Publikováno v:
Cancer Research. 83:4534-4534
Introduction: With the increasing complexity of current diagnostic investigations, the integration of clinical, pathological and molecular characteristics is crucial for the management of patients (pts) with cancers of unknown primary (CUP). A nation